These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22294342)

  • 21. Infliximab for the treatment of orofacial Crohn's disease.
    Mahadevan U; Sandborn WJ
    Inflamm Bowel Dis; 2001 Feb; 7(1):38-42. PubMed ID: 11233659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab-induced psoriasis during therapy for Crohn's disease.
    Steinwurz F; Denadai R; Saad-Hossne R; Queiroz ML; Teixeira FV; Romiti R
    J Crohns Colitis; 2012 Jun; 6(5):610-6. PubMed ID: 22398095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "How to manage loss of response to anti-TNF in Crohn's disease? ".
    Reinisch W
    Curr Drug Targets; 2010 Feb; 11(2):152-5. PubMed ID: 20210764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
    Sisman G; Erzin Y; Bal K
    J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.
    Emmert MY; Salzberg SP; Emmert LS; Behjati S; Plass A; Felix C; Falk V; Gruenenfelder J
    Eur J Heart Fail; 2009 Nov; 11(11):1106-9. PubMed ID: 19875411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
    Heidemann J; Kucharzik T
    Z Gastroenterol; 2005 Jul; 43(7):689-90. PubMed ID: 16001352
    [No Abstract]   [Full Text] [Related]  

  • 27. Infliximab (Remicade) and increased incidence of development of basal cell carcinoma.
    Gaines-Cardone E; Hale EK
    J Drugs Dermatol; 2012 May; 11(5):655-6. PubMed ID: 22527438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
    Cravo M; Silva R; Serrano M
    BioDrugs; 2010 Dec; 24 Suppl 1():25-7. PubMed ID: 21175232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A; Leite S; Cotter J
    BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
    Fidalgo C; Calado J; Cravo M
    BioDrugs; 2010 Dec; 24 Suppl 1():15-7. PubMed ID: 21175229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical mycobacteria: showerheads, anti-TNF therapy and Crohn's disease.
    Desai AA; Marks DJ
    Expert Rev Clin Immunol; 2010 Sep; 6(5):695-9. PubMed ID: 20828275
    [No Abstract]   [Full Text] [Related]  

  • 32. First case report of adalimumab-induced psoriasis in Crohn's disease.
    Harris MD; Richards R
    Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
    [No Abstract]   [Full Text] [Related]  

  • 33. Psoriasis induced by infliximab in a patient suffering from Crohn's disease.
    Manni E; Barachini P
    Int J Immunopathol Pharmacol; 2009; 22(3):841-4. PubMed ID: 19822070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psoriasis induced by infliximab: a paradoxical event].
    González-López MA; Blanco-Alonso R; Yáñez-Díaz S; Fernández-Llaca H
    Med Clin (Barc); 2006 Sep; 127(8):316. PubMed ID: 16949022
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F; Nagy F; Szepes Z; Kiss I; Lonovics J; Molnár T
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract]   [Full Text] [Related]  

  • 36. Colon cancer after infliximab therapy for Crohn's disease.
    Ferreira F; Lopes S; Macedo G
    BioDrugs; 2010 Dec; 24 Suppl 1():18-21. PubMed ID: 21175230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oligosymptomatic alimentary tract perforation in course of Crohn's disease in patient treated with anti-TNF alfa antibodies].
    Jałocha Ł; Wojtuń S; Wojtkowiak M; Błaszak A; Dyrla P; Gil J
    Pol Merkur Lekarski; 2009 May; 26(155):491-2. PubMed ID: 19606707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease.
    Levesque BG; Sandborn WJ
    Inflamm Bowel Dis; 2011 Jun; 17(6):1443-4. PubMed ID: 21560204
    [No Abstract]   [Full Text] [Related]  

  • 39. The management of fistulizing oral Crohn's disease with infliximab.
    Staines KS; Green R; Felix DH
    J Oral Pathol Med; 2007 Aug; 36(7):444-6. PubMed ID: 17617840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.
    Condino G; Calabrese E; Zorzi F; Onali S; Lolli E; De Biasio F; Ascolani M; Pallone F; Biancone L
    Dig Liver Dis; 2013 Mar; 45(3):258-62. PubMed ID: 23195667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.